NASDAQ: GRAL - GRAIL, LLC

Yield per half year: +178.5%
Dividend yield: 0%
Sector: Healthcare

Share chart GRAIL, LLC

Extended chart Simple chart
Financial Markets by TradingView

About GRAIL, LLC

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2024-06-25
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://grail.com
Цена ао 42.89
Change price per day: 0% (38.99)
Change price per week: +10.77% (35.2)
Change price per month: +47.13% (26.5)
Change price per 3 month: -29.13% (55.02)
Change price per half year: +178.5% (14)
Change price per year to date: +108.28% (18.72)
All parameters

Underestimation

Title Value Grade
P/S 4.53 3
P/BV 0.2275 10
P/E 0 0
EV/EBITDA -0.6938 0
Total: 5.38

Efficiency

Title Value Grade
ROA, % -58.78 0
ROE, % -65.92 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1117 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 759.53 10
Yield Ebitda, % 97.64 9
Yield EPS, % 2417.27 10
Total: 9.8
More

ETFShare, %Profitability for 1 year, %Dividends, %
Principal Healthcare Innovators ETF 0.04203 618.5 0.8416
Future Tech ETF 0.04203 426.34 0.8416
0.04522.420.84



Head Job title Payment Year of birth
Mr. Robert P. Ragusa CEO & Director 1960 (65 years)
Dr. Joshua J. Ofman M.D., M.S.H.S President 1965 (60 years)
Mr. Aaron Freidin Chief Financial Officer
Mr. Paul Ciccolella Senior VP of Global Development & Operations
Ms. Amoolya Singh Ph.D. Senior VP of Research & Chief Scientific Officer
Mr. Abram Barth J.D., M.P.H. General Counsel
Ms. Julie Currie Chief People Officer
Mr. Rodger Currie VP and Head of Government Affairs & Alliance Development
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng President Biopharma Business & Europe
Dr. Satnam Alag Ph.D. Senior VP of Software Engineering & Chief Security Officer

Address: United States, Menlo Park, 1525 O’Brien Drive - open in Google maps, open in Yandex maps
Website: https://grail.com